Global cannabis testing market size is estimated at USD 2.86 Bn in 2025 and is expected to reach USD 8.55 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.9% from 2025 to 2032.

To learn more about this report, Download Free Sample
The global cannabis testing market is experiencing robust growth driven by regulatory evolution, technological innovation, and increasing demand for product safety. North America dominates revenue generation, accounting for the largest market share due to mature legal frameworks and commercial cannabis adoption.
|
Current Events |
Description and its impact |
|
Global Cannabis Legalization Trends |
|
|
Economic Conditions & Market Investment Trends |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
An emerging and largely untapped application within the cannabis testing market is the comprehensive genetic or DNA-based cannabis testing. For instance, Medicinal Genomics, a biotechnology company, introduced technology enabling cannabis cultivators and processors to screen for harmful pathogens, potency prediction, and strain authenticity using genetic sequencing methods.
The cannabis testing market is experiencing growth due to increasing legalization and the implementation of regulatory requirements across various regions. Neotron, an Italy-based ISO-accredited laboratory, provides a comprehensive portfolio of cannabis testing services aligned with both national and European pharmaceutical standards.
The global cannabis operators require the EU-GMP certification to get access in the European market. The Cannabis Reform Law passed in April 2024 has removed restrictions on domestic producers in Germany. However, in 2024, Germany has imported over 72 tons of cannabis. This highlights that imported cannabis is expected to remain dominant for years to come.
Technological advancements in analytical instruments like chromatography and mass spectrometry are enhancing testing accuracy and efficiency. The adoption of Laboratory Information Management Systems (LIMS) is streamlining workflows.
Creative service models, such as mobile and on-site testing, are emerging to cater to diverse industry needs. Moreover, the development of rapid testing methods and user-friendly kits is increasing accessibility. These service and technological innovations are contributing to a more efficient cannabis testing ecosystem.
In May 2023, Trichome Analytical, a U.S.-based laboratory, announced the licensing of PhytoFacts. It is a cannabis analytical data tool. Through this tool, Trichome aims to provide clients with a comprehensive profile and deeper insights into the cannabis they test.
The emergence of new testing methods can offer growth opportunity for global cannabis testing market. The Advanced analytical techniques allow for more comprehensive product quality screening than ever before. Technological advancements in testing methods, including chromatography and spectroscopy, are enhancing efficiency and accuracy, creating opportunities for innovation in testing services and equipment.
In 2024, Agilent Technologies introduced its next-generation InfinityLab LC Series portfolio, representing a significant advancement in liquid chromatography technology for various applications, including cannabis testing.
In terms of service type, potency testing segment is estimated to contribute the highest market share of 25.5% in 2025, owing to strict regulations.
As the legal cannabis market expand worldwide, ensuring product safety and consistency becomes crucial. Potency testing determines the amount or concentration of THC, CBD, and other cannabinoids in a sample. Precise potency measurements are important for compliance with legal limits and for manufacturers to develop accurate dosage formulations.
In terms of product type, analytical instruments segment is estimated to contribute the highest market share of 45.5% in 2025, due to rising complexity of product formulations.
Analytical instruments offer the selectivity and precision that are needed to test novel product formulations as businesses expand into new categories. This analytical capability allows for consistent manufacturing of advanced goods. For instance, in 2023, Shimadzu Corporation, a Japan-based company, launched Brevis GC 2050 gas chromatograph. This chromatograph is used for cannabis testing.
In terms of end user, cannabis drug manufacturers segment is estimated to contribute the highest market share of 51.5% in 2025, owing to stringent regulatory requirements.
Manufacturers face strict guidelines by health agencies when developing and producing cannabis-based medicines, edibles, extracts and other consumer goods. Failing product tests can lead to costly waste disposal, damage to brand reputation, and in severe cases regulatory non-compliance penalties. Comprehensive testing smoothens new product approvals and regulates interstate commerce activities.

To learn more about this report, Download Free Sample
North America has been the dominant region in the global cannabis testing market with an estimated market share of 40.8% in 2025, primarily due to legalization of both medical and recreational marijuana in major markets like the U.S. and Canada. Countries in this region have made meaningful investments in building a strong testing infrastructure to ensure product safety and quality.
The cannabis testing market in the Asia Pacific region is gaining momentum as more countries, such as Australia and Thailand, legalize medical use. This growing acceptance is driving a greater need for thorough testing to guarantee product safety for patients. The growing demand for dependable and safe cannabis products is creating substantial avenues for expansion within the Asia Pacific testing industry.
U.S. Cannabis Testing Market is expected to exhibit a CAGR of 10.5% during the forecast period. The West Coast, especially California, Oregon, and Colorado, remains the most mature market due to early legalization and high production volumes.
China’s cannabis testing market is marked by rapid expansion, driven by advancements in testing technologies and a gradually evolving regulatory framework. The market presents substantial growth opportunities, particularly in industrial hemp testing. However, challenges remain, including strict government oversight, lack of standardized testing protocols, and high barriers to entry for foreign and private laboratories.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.86 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 16.9% | 2032 Value Projection: | USD 8.55 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Anresco, SC Labs, Inc, CW Analytical Laboratories, Digipath, Inc, EVIO, Inc, Eurofins Scientific, Pure Analytics LLC, Green Scientific Labs, Steep Hills, Inc, PharmLabs, Agilent Technologies Inc., Shimadzu Scientific Instruments, Restek Corporation, PerkinElmer Inc., Danaher Corporation, Accelerated Technology Laboratories Inc., Steep Hill Halent Laboratories Inc., Digipath Inc., LLC, Sartorius AG |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Databases:
Magazines:
Newspapers:
Proprietary Elements:
*Definition: Global Cannabis Testing Market involves the testing of cannabis and cannabis-derived products for various quality parameters like potency, pesticides, residual solvents, bacteria and other contaminants. This market includes testing for both medical and recreational cannabis to ensure product safety and compliance with regulations. The testing helps produce high quality and consistent cannabis and cannabis products while protecting consumer health. Various testing methods are used like chromatography testing, potency testing and terpene profiling. The market is evolving with the legalization of medical and recreational cannabis in many countries.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients